Clinical trials recruiting in Miyakonojō, Japan

Phase breakdown

Conditions recruiting in Miyakonojō, Japan

Recruiting trials in Miyakonojō, Japan

• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
  NCT07288567 · Phase: Phase 3 · Ages: 13 Years to 17 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
  NCT06882785 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
  NCT07424404 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Miyakonojō, Japan?

3 recruiting trials have at least one study site in Miyakonojō, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.